ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 187 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 3 | 0.0% | 0.00% | – |
Q2 2023 | $0 | – | 3 | 0.0% | 0.00% | – |
Q1 2023 | $0 | – | 3 | 0.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 3 | -99.1% | 0.00% | – |
Q1 2022 | $9,000 | -43.8% | 329 | -3.2% | 0.00% | – |
Q4 2021 | $16,000 | – | 340 | +6700.0% | 0.00% | – |
Q2 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
Q1 2021 | $0 | – | 5 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 5 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
Q3 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 5 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 327,929 | $9,218,000 | 3.24% |
Parkman Healthcare Partners LLC | 107,911 | $3,033,000 | 0.89% |
Global Alpha Capital Management Ltd. | 350,231 | $9,845,000 | 0.85% |
MARATHON CAPITAL MANAGEMENT | 75,010 | $2,109,000 | 0.60% |
TANG CAPITAL MANAGEMENT LLC | 100,000 | $2,811,000 | 0.56% |
EMERALD ADVISERS, LLC | 354,045 | $9,952,000 | 0.38% |
Sio Capital Management, LLC | 40,000 | $1,124,000 | 0.37% |
EMERALD MUTUAL FUND ADVISERS TRUST | 299,493 | $8,419,000 | 0.37% |
Stonepine Capital Management, LLC | 26,060 | $733,000 | 0.30% |
Mitsubishi UFJ Asset Management (UK) Ltd. | 23,000 | $646,530,000 | 0.29% |